FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

377450006: Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3679457016 Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3679458014 Guaifenesin 91.44 mg and theophylline 152.4 mg oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) Is a Product containing theophylline (medicinal product) false Inferred relationship Some
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) Is a Theophylline-containing product in oral dose form false Inferred relationship Some
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Theophylline (substance) false Inferred relationship Some
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Smooth muscle relaxant (substance) false Inferred relationship Some
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) Is a Product containing guaifenesin and theophylline (medicinal product) false Inferred relationship Some
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Guaifenesin false Inferred relationship Some
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) Has manufactured dose form A solid single-dose form that is a shell made of gelatin or other substances. The contents of the shell may be a solid, semi-solid or liquid. false Inferred relationship Some
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Xanthine false Inferred relationship Some
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. agent de l'appareil locomoteur false Inferred relationship Some
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) Has manufactured dose form Oral capsule true Inferred relationship Some
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) Is a Theophylline-containing product in oral dose form false Inferred relationship Some
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Theophylline (substance) false Inferred relationship Some 1
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Theophylline (substance) true Inferred relationship Some 1
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator value 152.4 false Inferred relationship Some 1
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 1
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value un false Inferred relationship Some 1
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. Capsule (unit of presentation) true Inferred relationship Some 1
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Guaifenesin false Inferred relationship Some 2
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Guaifenesin true Inferred relationship Some 2
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator value 91.44 false Inferred relationship Some 2
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 2
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value un false Inferred relationship Some 2
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. Capsule (unit of presentation) true Inferred relationship Some 2
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Guaifenesin false Inferred relationship Some 1
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator value 91.44 false Inferred relationship Some 1
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Theophylline (substance) false Inferred relationship Some 2
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator value 152.4 false Inferred relationship Some 2
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) Has unit of presentation Capsule (unit of presentation) true Inferred relationship Some
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Theophylline (substance) false Inferred relationship Some 2
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Guaifenesin false Inferred relationship Some 1
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) Is a Guaifenesin- and theophylline-containing product in oral dose form false Inferred relationship Some
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient deux false Inferred relationship Some
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) Is a Product containing only guaifenesin and theophylline in oral dose form (medicinal product form) true Inferred relationship Some
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) Plays role Expectorant therapeutic role false Inferred relationship Some
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Theophylline (substance) true Inferred relationship Some 1
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Guaifenesin true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start